AgomAb Therapeutics NV · NASDAQ:AGMB
Epstein David R bought 5,000 AgomAb Therapeutics NV shares (Form 4)
Traded Nov 17, 2026 · Filed Nov 19, 2026
On Nov 17, 2026, Epstein David R (Director) bought 5,000 AgomAb Therapeutics NV shares at US$5.57 for US$27,850, leaving 59,980 shares. Filed Nov 19, 2026 (Form 4).
- Bought
- 5,000 shares
- Price
- US$5.57
- Value
- US$27,850
- Holding after
- 59,980 shares
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Nov 17, 2026 | Common shares | Buy | 5,000 | US$5.57 | 59,980 | Direct |
Source
Download original · View original at SEC